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1 Abstract 
 
Cell organelles concerned with parathyroid hormone secretion were shown to become 
enlarged 6 to 10 hours after application of estrogens to rats, suggesting that estrogens may 
stimulate parathyroid hormone secretion. To test whether this assumption is correct we treated 
cattle with estrogens and collected blood samples in 1 hour intervals for the first 10 hours, and 
thereafter in 2 hours intervals up to 24 hours. Analysis of plasma parathyroid hormone by 
radioimmunoassay revealed increments of parathyroid hormone that were mostly not 
negatively correlated with plasma calcium concentration. The responses to application of 
estrogen varied enormously considering magnitude and onset of alterations in parathyroid 
hormone, estrogen and calcium concentration. The data strongly suggest that estrogens have 
the ability to stimulate parathyroid hormone secretion via a genomic pathway because of the 
presence of estrogen receptors in bovine parathyroid cell nuclei detected by immunolabeling. 
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2 Introduction  
 
2.1 PTH 
 
The concentration of plasma parathyroid hormone (PTH) is inversely related to the 
concentration of plasma calcium (Arnaud and Tsao, 1969; Care et al., 1966; Ramberg et al., 
1967; Sherwood et al., 1966; Sherwood et al., 1968). PTH synthesis and PTH release are 
mainly controlled by calcium via a unique negative feedback mechanism (Habener and Potts, 
1976). Though parathyroid secretory activity is largely controlled by calcium, magnesium 
plays also an essential role (Sherwood, 1970; Sherwood et al., 1970). Many other cationic 
factors, e.g. manganese (Johansson et al., 1988),  sodium, potassium (Brown et al., 1987), 
lithium, aluminum (Cournot-Witmer and Plachot, 1990), fluoride and chloride (Brown, 1982; 
Cannata et al., 1988; Shoback and McGhee, 1988), are involved in modulation of PTH 
secretion. Furthermore, non-ionic factors such as β-adrenergic catecholamines, prostaglandins 
E2, serotonin, prolactin, dopamine and glucagon (Brown, 1982; Cannata et al., 1988; Habener, 
1981) were shown to stimulate PTH secretion whereas α-adrenergic catecholamines, 
somatostatin and prostaglandines F2 were reported to suppress PTH secretion (Brown, 1982). 
 
2.2 Estrogen 
 
Estrogens are also involved in PTH secretion. However, diverging opinions exist wether 
estrogens modify PTH secretion directly (Duarte et al., 1988; Greenberg et al., 1987; Naveh-
Many et al., 1992; Shen et al., 2000; Silver et al., 1994) or indirectly via hypocalcaemia 
resulting from inhibition of  calcium resorption from bone (Gallagher et al., 1980; Prince et 
al., 1991; Saxe et al., 1992; Shen et al., 2000; Vincent et al., 2003). In vitro studies on isolated 
parathyroid cells revealed clear evidence that E2 has a direct effect on PTH secretion 
(Greenberg et al., 1987).  
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2.3 Regulation of PTH synthesis and release 
 
PTH is synthesized on ribosomes of the rough endoplasmic reticulum (RER), packaged in the 
Golgi complex into secretory granules for storage and transportation to the cell periphery 
where it is released by exocytosis (Habener, 1981). Autoradiographic studies showed that the 
whole process takes about 30 min (Habener et al., 1979). PTH release is modulated within 
seconds (Blum et al., 1974). To modulate PTH synthesis hours are required (Habener, 1981). 
Administration of β-estradiol-3-benzoate (E2) to rats provoked an initial membrane shift from 
the Golgi complex and secretory granules to the plasma membrane in parathyroid (PT) cells 
within 90 minutes suggesting that PTH release has been provoked by estradiol (Wild et al., 
1989) because a similar membrane shift was apparent in PT cells stimulated by depression of 
serum calcium (Wild et al., 1982). In addition, a transient depression of serum calcium 
resulted in drastic enlargement of the compartments concerned with PTH synthesis after more 
than 6 hours suggesting increment of capacity for PTH production (Wild et al., 1985). 
Similarly, compartments concerned with PTH secretion were also substantially enlarged 6 
hours after E2 treatment suggesting that estradiol modulates also the capacity for PTH 
synthesis, packaging and storage. (Wild et al., 1989).  
 
2.4 Aim of the study 
 
On the basis of the behavior of membranes concerned with PTH secretion we tested whether 
estradiol stimulates, indeed, PTH release within minutes. Therefore, we treated cattle with E2 
and took blood samples every 15 min for analysis of E2, PTH and calcium. To evaluate 
whether estradiol influences PTH synthesis cattle were treated with 4 consecutive injections 
of E2 in intervals of 2 h because a minimal exposure time for 6 h was required to stimulate 
membrane synthesis necessary for enlargement of the PTH synthesis machinery (Wild et al., 
1989). The data suggest that E2 may have an effect on PTH synthesis probably via a genomic 
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pathway as immunolabeling for E2 receptors in PT cells was positive. The short-term effect 
on PTH release could not be convincingly demonstrated. 
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3 Materials and methods 
 
3.1 Experimental Design 
 
Six 3 to 4 years old non lactating cattle in the anestrous phase of the Swiss brown breed kept 
on a diary farm were used for this study. 0.01 mg E2/kg body weight (beta-estradiol-3-
benzoate; Streuli, Uznach, Switzerland) was administered by intramuscular injection into the 
gluteal muscle at 0, 2, 4, and 6 h as it had been shown that it takes at least 6 h of E2 exposure 
to activate the machinery for PTH synthesis and packaging  (Wild et al., 1989). Blood 
samples were taken through a catheter (Becton & Dickinson, Rutherford, NY, USA) 
implanted into a jugular vein 24 h prior to the first E2 administration. Samples were taken 
every hour from 0 to 10 h of the experiment, and then in intervals of 2 h up to 24 h. For 
controls, 4 cattle received 4 times the vehicle substance. Blood sample were taken in 15 min 
intervals during the first 2 h and then in same intervals as described. In addition, these animals 
received a single dose of E2 at 24 h. Blood samples were taken in intervals of 15 minutes 
during 2 hours after E2 administration in order to determine a possible short term effect of E2 
on PTH release. Blood was collected in 20 ml syringes containing heparin (B. Braun, 
Melsungen, Germany) and centrifuged at low speed. 1.5 ml aliquots of plasma were frozen 
within 15 minutes after collection and stored at -20°C. 
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3.2 Determination of plasma calcium concentration 
 
The plasma calcium concentration was determined employing a spectroscopy calcium test 
(Böhringer, Mannheim, Germany) according to the o-kresolphtalein-complex-method without 
withdrawal of proteins (Ray Sacar B.C. et al. 1967). The analysis was checked with a control 
serum (Precinorm U, Böhringer, Mannheim, Germany). 
 
3.3 Estimation of parathyroid hormone and estradiol 
 
Plasma PTH concentration was determined by radioimmunoassay using kits from Nichols 
Institute Diagnostics (Chantilly, Virginia, USA). In a preliminary experiment we checked the 
efficiency of the method for bovine PTH after induction of hypocalcemia. 1.25 mg/kg body 
weight ethylene-glycol-tetra acetic-acid (EGTA, Fluka, Buchs, Switzerland) was infused into 
a jugular vein at a speed of 0.5 ml/min for 7 minutes according to (Blum et al., 1974). 10 
blood samples were taken from the other jugular vein in 15 min intervals for determination of 
calcium concentration and PTH. The detection limit was 12 ng/ml. Plasma concentration of 
E2 was determined by radioimmunoassay using kits from Immunotech (Marseille, France). 
The detection limit was 0.45 pg/ml. Data were analyzed by a multiple t test using the Prisma 
software. 
 
3.4 Immunocytochemistry 
 
Bovine PT glands were harvested at the local abattoir. They were immersed into ice chilled 
0.1 M Na-phosphate, pH 7.2, for transportation to the laboratory for fixation with 2% 
paraformaldehyde at room temperature for 30 min. After freezing cryo-sections were prepared 
and immunostained for E-receptors using monoclonal antibodies (Abbott Laboratories, 
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Abbott Park, Illinois, USA). For controls, samples from the endometrium of the same cattle 
were used. For controls samples of the uterus of the same animals were used.  
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4 Results 
 
Administration of E2 resulted in marked alterations of plasma PTH concentration that varied 
considerably among animals considering magnitude and time of onset. Statistical analysis of 
PTH and of plasma calcium concentration thus did not reveal any significant differences. 
Therefore, data of individual animals were compared and described in detail.  
 
4.1 Alterations of E2, PTH and calcium from 0 to 10 hours 
 
The compartments concerned with PTH synthesis have been shown to be drastically increased 
6 to 12 after an initial depression of serum calcium (Wild et al., 1984) or after 4 consecutive 
applications of E2 (Wild et al., 1989) in rat PT cells suggesting enhancement of the capacity 
for PTH synthesis and possibly of PTH release. To verify whether or not estradiol influences 
PTH synthesis we administered E2 four times in intervals of 2 h. As shown in Fig. 1 E2 
increased dramatically from 4 to 150-200 pg/ml within 3 hours in 2 animals (C1 and C2). E2 
fluctuated at this level in C1 for about 10 h whereas in C2 it declined to 80 pg/ml at 4 h 
followed by a steady increase to 110 pg/ml at 10 h. E2 rose continuously in C3, rose 
drastically in C5 from 5th to 6th h but rose slowly in C4 and C6 to 57 and 20 pg/ml, 
respectively. The heterogeneity in response to E2 administration considering time and 
magnitude suggests great variations in PTH concentrations if E2 has has an effect on PTH 
secretion. Indeed, in C1 PTH increased drastically to a first peak at 3 h and to a maximum of 
167 ng/ml at 8 h. In C2 PTH rose only to 56 ng/ml at 3 h, and to 140 ng/ml at 7 h after the 
first injection of E2. PTH peaked at 5 h in C3 (60 ng/ml) and C6 (88 ng/ml), and at 8 h in C5 
starting to rise at 7 h after the first application of E2. C4 showed no response. Interestingly, 
PTH declined (except in C1) during the first 2 hours but rose slightly from the 2nd to the 3rd h. 
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To clarify whether the increments of PTH are a direct effect of E2 onto the secretory activity 
of PT cells we compared the PTH peaks with alterations of plasma calcium. In C1 and C2 all 
PTH peaks were positively correlated with [Ca++]. The PTH peak at 5h in C3 was inversely 
related to changes in [Ca++]. However, the decrease of [Ca++] by only 0.2 mmol/ml does not 
justify the assumption that it was responsible for the rise in PTH of more than 40 ng/ml at 5 h. 
Plasma [Ca++] in C5 dropped by 1.25 mmol/ml between 6 and 7 h without concomitant rise in 
PTH. Therefore, the minor decrease of 0.2 mmol from 7 to 8 h is unlikely to be responsible 
for the rise in PTH of 90 ng/ml especially since [Ca++] remained constant for the next hour 
whereas PTH drastically decreased. The rise in PTH of 60 ng/ml from 4 to 5 h in C6 
correlated with a decrease in [Ca++] of 0.5 mmol/mml whereas the PTH peak at 7 h was 
positively related to [Ca++]. These data strongly suggest that changes in [Ca++] were not 
primarily responsible for the marked increments of PTH and that E2 played the major role in 
regulation of PTH secretion.  
 13
 
 
Fig. 1 Plasma E2, PTH and Ca++ concentration of blood samples taken form 0 to 10 h after 
administration of E2. 
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Fig. 2 Plasma E2, PTH and Ca++ concentration of blood samples taken form 0 to 10 h after 
administration of the carrier substance. 
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PTH decreased within the first h but increased to 40 ng/ml at 4 h. This increase was also 
positively related to an increase in calcium and E2 whereby the increase in E2 was more 
pronounced than that of calcium. These data suggest that the increase in PTH was rather due 
to physiological changes in E2 than by changes in calcium concentration. Alternatively, it 
might have been caused by other factors such as stress. All other data were within normal 
ranges suggesting that the rise of PTH in E2 treated animals was a response of PT cells to E2. 
 
4.2 Alterations of E2, PTH and calcium from 10 to 24 hours 
 
If the idea is correct that enlargement of the machinery of PTH secretion as detected at 12 h 
after a single massive depression of calcium concentration (Wild et al., 1985) or after 
administration of E2 (Wild et al., 1989) in rats it will be expected that plasma PTH 
concentration will stay at a high level or even further increase after 10 h of exposure to a 
stimulating agent. Determination of PTH (Fig. 3) revealed fluctuations in C1 and C2 reaching 
peaks at 14 h (C1: 160 ng/ml) and 16 h (C2: 180 g/ml), respectively. Then PTH declined in 
both animals to about 70 ng/ml at 24 h. PTH fluctuated between 20 and 50 ng/ml in C3 and 
C4. In C5 PTH started to rise after 18 h to 84 ng/ml whereas in C6 PTH started to rise at 20 h 
almost to 120 ng/ml. The marked depression of PTH in C1 and C2 at 12 h was negatively 
correlated with [Ca++] whereas the peaks at 14 h (C1) and 16 h (C2) were not. In C1 [Ca++] 
fluctuated between 2.6 and 2.5 mmol/ml from 12 to 18 h, and increased to 2.9 mmol/ml at 20 
h. The increment of PTH in C1 from 12 to 14 h was followed by a drastic decrease to 84ng/ml 
at 16 h whereas there was only a minor decrease of PTH from 18 to 20 h at the time [Ca++] 
rose by 0.4 mmol/ml. In C2 PTH increased drastically from 12 to 16 h whereas [Ca++] 
increase from 14 to 18 h. In C5 [Ca++] increased from 1.7 mmol/ml at 12 h to 2.7 mmol/ml at 
16 h, and rapidly decreased to 1.6. mmol/ml at 20 h. PTH increased slowly from 10 to 18 h 
but fast from 18 to 20 h. In C6 there were little changes in PTH between 10 and 20 h despite a 
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remarkable decrease of [Ca++] from 16 to 18 h. However, PTH rose drastically from 20 to 22 
h whereas [Ca++] rose from 18 to 22 h. These data show that alterations in PTH were mostly 
not negatively related to changes in [Ca++]. 
 
 
Fig. 3. Plasma E2, PTH and Ca++ concentration of blood samples taken form 10 to 24 h in 2 
hours intervals after administration of E2. 
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Administration of the carrier substance had no obvious effect between 10 and 24 h (Fig. 4). 
Variations in PTH, [Ca++] and E2 were low. Changes in PTH were often but not always 
negatively correlated with [Ca++] which varied maximally within a range of 0.2 mmol/ml in a 
given animal. The range of E2 did not exceed 1 pg/ml and that of PTH was maximal 20 ng/ml 
in a given animal. 
 
 
Fig. 4 Plasma E2, PTH and Ca++ concentration of blood samples taken form 10 to 24 h in 2 
hours intervals after administration of the carrier substance. 
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4.3 Short-term Alterations of E2, PTH and calcium 
 
To clarify whether E2 may have a short-term effect on PTH release, a single dose of E2 was 
injected to the animals 24 hours after treatment with the carrier substance. Analyses of blood 
samples taken in intervals of 15 min revealed a rise of PTH at 15 min in 2 of the 4 animals 
(Fig.5) that were accompanied by a decrease in [Ca++]. However, the rise in PTH was more 
than 20 ng/ml in C8 and C9 whereas the decrease in [Ca++] was less than 0.1 mmol/ml. PTH 
peaked also at 75 min in C7, C8 and C9. The rises in PTH from 60 to 75 min were positively 
correlated with [Ca++] in C8 and C9. The rise of PTH from 60 to 120 min in C8 can also not 
be attributed to decrements in [Ca++].  
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Fig. 5 Plasma E2, PTH and Ca++ concentration of blood samples taken form 0 to 120 min in 
15 minutes intervals after administration of E2. 
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Fig. 6 Plasma E2, PTH and Ca++ concentration of blood samples taken form 0 to 120 min in 
15 minutes intervals after administration of the carrier substance. 
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4.4 E2 receptors are present on parathyroid cell nuclei  
 
The increments in PTH after 5 h of the first administration of E2 are rather due to E2 than to 
decrements of [Ca++] because variations in plasma [Ca++] were small and not always 
negatively correlated to rises in PTH. The late response of PTH secretion to E2 suggests a 
genomic pathway involving E2 receptors (Naveh-Many et al., 1992) at least after application 
of estradiol. Immunolabeling of bovine PT tissue harvested at a local abattoir yielded faint 
staining of PT cell nuclei for E2 (Fig. 7) as was claimed to be the locus in intact cells (King 
and Greene, 1984; Welshons et al., 1984).  
 
 
 
Fig. 7 Immunostaining of parathyroid cells (A) and endometrial glands (C) with monoclonal 
antibodies against estrogen receptors. For negative controls primary antibody was avoided in 
cryo-sections of parathyroid (B) and endometrial glands (D) 
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5 Discussion 
 
This study was designed to evaluate the effect of estrogens on parathyroid PT secretory 
activity on the basis of results obtained in studies on membrane dynamics in rat PT cells that 
showed substantial response to E2 after administration in 4 consecutive steps in intervals of 2 
h (Wild et al., 1989). Analysis of blood collected from cattle treated with 4 consecutive 
injections of E2 clearly revealed that E2 has the ability to stimulate PTH secretion as the 
enlargement of the machinery concerned with PTH secretion had suggested. The response to 
E2 administration varied considerably among the animals in respect to onset and magnitude. 
Administration of β-estradiol-3-benzoate, a formulation designed for intramuscular injection, 
resulted in a rapid rise in plasma E2 starting after 2 h and in a first increase of plasma PTH at 
3 h followed by a second increase starting at 5h in C1 and C2. The increments were not 
related to decrements in [Ca++] (Fig. 8) and are hence considered likely to be the result of a 
stimulating effect of E2 on PT secretory activity. Increments of PTH in the other animals were 
not as dramatic as in C1/C2 and occurred later. Increments of PTH in C5 and C6 were less 
pronounced, occurred later and were not or not clearly related to decrements in [Ca++]. C3 and 
C4 showed little response on PTH. Interestingly, [Ca++] increased substantially between 2 and 
4 h in C1 and C3, but later in the other animals. Most [Ca++] increments were not negatively 
related with PTH, except in C3. The early rises in [Ca++] are considered likely to be the result 
of a hypocalcemic effect of estrogens (Prince et al., 1990), which in turn results from 
estrogen-mediated inhibition of bone resorption (Gallagher et al., 1980; Riggs and Melton, 
1986; VanHouten and Wysolmerski, 2003). PTH was considered to stimulate osteoblast 
function after pretreatment with estrogens (Nasu et al., 2000). On the other hand, estrogens 
stimulate gene expression and production of osteoprotegerin in osteoblastic cells that is 
supposed to play a major role in the antiresorptive action of estrogens in bone (Hofbauer et 
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al., 1999). It has also been shown that PTH was significantly higher during the estrus in 
weanling rats (Epstein et al., 1996).  
 
 
Fig. 8  Plasma E2, PTH and Ca++ concentration of blood samples taken form 0 to 10 h of 
cattle C1 and C3 after administration of E2. 
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Despite the heterogeneity of the responses there is little doubt about a direct stimulating effect 
of E2 on PT secretory activity. The presence of estrogen-receptors on PT cell nuclei suggests a 
genomic pathway (McCarty et al., 1983; Migliaccio and Marino, 2003; Moggs and 
Orphanides, 2001). The conclusion, however, whether or not E2 may modulate immediately 
PTH release cannot be deduced from the data obtained from blood samples collected in 15 
min intervals because of the heterogeneity in responses, the small increases of PTH and 
because of decrements in [Ca++] – although very low – accompanying PTH increments. A 
short but distinct depression of [Ca++] was shown to be sufficient to induce a rapid release of 
PTH resulting in a drastic increase of PTH within 7 min (Blum et al., 1974). On the other 
hand, release of PTH was also shown to be stimulated by estrogens in isolated human PT 
glands (Duarte et al., 1988) and bovine PT tissue culture (Greenberg et al., 1987). However, 
estrogens were reported to have no direct effect on PTH secretion in post menopausal women 
3 days after transdermal application (Vincent et al., 2003).  
 
Whether E2 may modulate PTH release has probably a much less physiological significance 
than its ability to stimulate PTH synthesis. The ability of E2 to stimulate PTH synthesis may 
be of importance in bone remodeling, and consequently, in the onset of e.g. osteoporosis in 
humans. Alternatively, it might play a role in the pathogenesis of hypocalcemia in cattle. E2 
increases prior to parturition (Eissa and el-Belely, 1990) that may or may not sufficiently 
stimulate PTH synthesis before the decrement of serum calcium due to the high demand 
provoked by producing milk. The ability of E2 to stimulate PTH synthesis may also be used to 
prevent the onset of post-parturient hypocalcemia. Stimulation of PT secretory activity prior 
to emergencies is extremely important because the storage capacity of PTH is low due to the 
low numbers of secretory granules in PT cells (Setoguti et al., 1995).  
 
 25
The heterogeneity in the response to administration of E2 had probably different reasons. One 
is the different absorption rate of substances injected intramuscularly. Beta-estradiol-3-
benzoate prepared as a crystalline suspension in water is rapidly absorbed after intramuscular 
administration and rapidly metabolized, the half-life time being 50 min according to the 
manufacturer (Streuli, Uznach, Switzerland). The fact that in 2 animals E2 increased only 
slowly and only for a few picograms suggests that absorption was for one or the other reason 
disturbed. Another reason might be the number of estrogen receptors present in PT cells. The 
weak staining detected on PT cell nuclei only without counterstaining using an interference 
microscope indicate that the number of estrogen receptors in PT cells are low. Other 
investigators could not show estrogen receptors at all in bovine and human parathyroid tissue 
(Prince et al., 1991; Saxe et al., 1992). It had been shown that the number of estrogen 
receptors varies, and that it increases after administration of estrogens in fish (Sabo-Attwood 
et al., 2007), in mammary tumor cells (Hannouche et al., 1982), and in PT cells and C-cells 
(Naveh-Many et al., 1992).  
 
Taken together, the data show that estrogens have the ability to stimulate PTH secretion. The 
diverse response in PTH secretion after administration of estrogen may be crucial e.g. in the 
onset of post-parturient hypocalcemia. 
 
 
 
 
 
 26
6 References 
 
Arnaud, C.D., and H.S. Tsao, 1969. Porcine calcitonin. Simple procedure for isolation in high 
yield. Biochemistry 8: 449-56. 
Blum, J.W., J.A. Fischer, D. Schwoerer, W. Hunziker, and U. Binswanger, 1974. Acute 
parathyroid hormone response: sensitivity, relationship to hypocalcemia, and rapidity. 
Endocrinology 95: 753-9. 
Brown, E.M., 1982. PTH secretion in vivo and in vitro. Regulation by calcium and other 
secretagogues. Mineral & Electrolyte Metabolism 8: 130-50. 
Brown, E.M., E.J. Watson, J.G. Thatcher, R. Koletsky, B.F. Dawson-Hughes, J.T. Posillico, 
and D.M. Shoback, 1987. Quabain and low extracellular potassium inhibit PTH 
secretion from bovine parathyroid cells by a mechanism that does not involve 
increases in the cytosolic calcium concentration. Metabolism 36: 36-42. 
Cannata, J.B., J.B. Diaz Lopez, M.J. Fernandez Menendez, and M.J. Virgos, 1988. The 
parathyroid gland and aluminum overload: an overview. Contributions to Nephrology 
64: 113-9. 
Care, A.D., L.M. Sherwood, J.T. Potts, Jr., and G.D. Aurbach, 1966. Perfusion of the isolated 
parathyroid gland of the goat and sheep. Nature 209: 55-7. 
Cournot-Witmer, G., and J.J. Plachot, 1990. Parathyroid glands in chronic aluminum 
intoxication. Ultrastructural Pathology 14: 211-9. 
Duarte, B., G.K. Hargis, and S.C. Kukreja, 1988. Effects of estradiol and progesterone on 
parathyroid hormone secretion from human parathyroid tissue. Journal of Clinical 
Endocrinology & Metabolism 66: 584-7. 
Eissa, H.M., and M.S. el-Belely, 1990. Sequential changes in plasma progesterone, total 
oestrogens and corticosteroids in the cow throughout pregnancy and around 
parturition. British Veterinary Journal 146: 24-9. 
 27
Epstein, E., J. Silver, G. Almogi, N. Livni, and T. Naveh-Many, 1996. Parathyroid hormone 
mRNA levels are increased by progestins and vary during rat estrous cycle. American 
Journal of Physiology 270: E158-63. 
Gallagher, J.C., B.L. Riggs, and H.F. DeLuca, 1980. Effect of estrogen on calcium absorption 
and serum vitamin D metabolites in postmenopausal osteoporosis. Journal of Clinical 
Endocrinology & Metabolism 51: 1359-64. 
Greenberg, C., S.C. Kukreja, E.N. Bowser, G.K. Hargis, W.J. Henderson, and G.A. Williams, 
1987. Parathyroid hormone secretion: effect of estradiol and progesterone. 
Metabolism: Clinical & Experimental 36: 151-4. 
Habener, J.F., 1981. Regulation of parathyroid hormone secretion and biosynthesis. Annual 
Review of Physiology 43: 211-23. 
Habener, J.F., and J.T. Potts, Jr., 1976. Relative effectiveness of magnesium and calcium on 
the secretion and biosynthesis of parathyroid hormone in vitro. Endocrinology 98: 
197-202. 
Habener, J.F., M. Amherdt, M. Ravazzola, and L. Orci, 1979. Parathyroid hormone 
biosynthesis. Correlation of conversion of biosynthetic precursors with intracellular 
protein migration as determined by electron microscope autoradiography. Journal of 
Cell Biology 80: 715-31. 
Hannouche, N., S. Samperez, M.R. Riviere, and P. Jouan, 1982. Estrogen and progesterone 
receptors in mammary tumors induced in rats by simultaneous administration of 17 
beta-estradiol and progesterone. Journal of Steroid Biochemistry 17: 415-9. 
Hofbauer, L.C., S. Khosla, C.R. Dunstan, D.L. Lacey, T.C. Spelsberg, and B.L. Riggs, 1999. 
Estrogen stimulates gene expression and protein production of osteoprotegerin in 
human osteoblastic cells. Endocrinology 140: 4367-70. 
 28
Johansson, H., R. Larsson, C. Wallfelt, J. Rastad, G. Akerstrom, and E. Gylfe, 1988. Calcium-
agonistic action of Mn2+ in the parathyroid cell. Molecular & Cellular Endocrinology 
59: 77-82. 
King, W.J., and G.L. Greene, 1984. Monoclonal antibodies localize oestrogen receptor in the 
nuclei of target cells. Nature 307: 745-7. 
McCarty, K.S., Jr., D.B. Lubahn, and K.S. McCarty, Sr., 1983. Oestrogen and progesterone 
receptors: physiological and pathological considerations. Clinics in Endocrinology & 
Metabolism 12: 133-54. 
Migliaccio, S., and M. Marino, 2003. Estrogens and estrogen receptors: new actors in the plot 
of transcriptional regulation of genomic responses. Calcified Tissue International 72: 
181-2. 
Moggs, J.G., and G. Orphanides, 2001. Estrogen receptors: orchestrators of pleiotropic 
cellular responses. EMBO Reports 2: 775-81. 
Nasu, M., T. Sugimoto, H. Kaji, and K. Chihara, 2000. Estrogen modulates osteoblast 
proliferation and function regulated by parathyroid hormone in osteoblastic SaOS-2 
cells: role of insulin-like growth factor (IGF)-I and IGF-binding protein-5. Journal of 
Endocrinology 167: 305-13. 
Naveh-Many, T., G. Almogi, N. Livni, and J. Silver, 1992. Estrogen receptors and biologic 
response in rat parathyroid tissue and C cells. Journal of Clinical Investigation 90: 
2434-8. 
Prince, R.L., I. Schiff, and R.M. Neer, 1990. Effects of transdermal estrogen replacement on 
parathyroid hormone secretion. Journal of Clinical Endocrinology & Metabolism 71: 
1284-7. 
Prince, R.L., D.T. MacLaughlin, R.D. Gaz, and R.M. Neer, 1991. Lack of evidence for 
estrogen receptors in human and bovine parathyroid tissue. Journal of Clinical 
Endocrinology & Metabolism 72: 1226-8. 
 29
Ramberg, C.F., Jr., G.P. Mayer, D.S. Kronfeld, G.D. Aurbach, L.M. Sherwood, and J.T. Potts, 
Jr., 1967. Plasma calcium and parathyroid hormone responses to EDTA infusion in the 
cow. American Journal of Physiology 213: 878-82. 
Riggs, B.L., and L.J. Melton, 3rd, 1986. Involutional osteoporosis. New England Journal of 
Medicine 314: 1676-86. 
Sabo-Attwood, T., J.L. Blum, K.J. Kroll, V. Patel, D. Birkholz, N.J. Szabo, S.Z. Fisher, R. 
McKenna, M. Campbell-Thompson, and N.D. Denslow, 2007. Distinct expression and 
activity profiles of largemouth bass (Micropterus salmoides) estrogen receptors in 
response to estradiol and nonylphenol. Journal of Molecular Endocrinology 39: 223-
37. 
Saxe, A.W., G.W. Gibson, I.H. Russo, and P. Gimotty, 1992. Measurement of estrogen and 
progesterone receptors in abnormal human parathyroid tissue. Calcified Tissue 
International 51: 344-7. 
Setoguti, T., Y. Inoue, and P. Wild, 1995. The biological significance of storage granules in 
rat parathyroid cells. Microscopy Research & Technique 32: 148-63. 
Shen, V., R. Birchman, D.D. Wu, and R. Lindsay, 2000. Skeletal effects of parathyroid 
hormone infusion in ovariectomized rats with or without estrogen repletion. Journal of 
Bone & Mineral Research 15: 740-6. 
Sherwood, L.M., 1970. Magnesium ion and parathyroid function. New England Journal of 
Medicine 282: 752. 
Sherwood, L.M., I. Herrman, and C.A. Bassett, 1970. Parathyroid hormone secretion in vitro: 
regulation by calcium and magnesium ions. Nature 225: 1056-8. 
Sherwood, L.M., J.T. Potts, Jr., A.D. Care, G.P. Mayer, and G.D. Aurbach, 1966. Evaluation 
by radioimmunoassay of factors controlling the secretion of parathyroid hormone. 
Nature 209: 52-5. 
 30
Sherwood, L.M., G.P. Mayer, C.F. Ramberg, Jr., D.S. Kronfeld, G.D. Aurbach, and J.T. Potts, 
Jr., 1968. Regulation of parathyroid hormone secretion: proportional control by 
calcium, lack of effect of phosphate. Endocrinology 83: 1043-51. 
Shoback, D.M., and J.M. McGhee, 1988. Fluoride stimulates the accumulation of inositol 
phosphates, increases intracellular free calcium, and inhibits parathyroid hormone 
release in dispersed bovine parathyroid cells. Endocrinology 122: 2833-9. 
Silver, J., E. Moallem, E. Epstein, R. Kilav, and T. Naveh-Many, 1994. New aspects in the 
control of parathyroid hormone secretion. Current Opinion in Nephrology & 
Hypertension 3: 379-85. 
VanHouten, J.N., and J.J. Wysolmerski, 2003. Low estrogen and high parathyroid hormone-
related peptide levels contribute to accelerated bone resorption and bone loss in 
lactating mice. Endocrinology 144: 5521-9. 
Vincent, A., B.L. Riggs, E.J. Atkinson, A.L. Oberg, and S. Khosla, 2003. Effect of estrogen 
replacement therapy on parathyroid hormone secretion in elderly postmenopausal women. 
Menopause 10: 165-71. 
Welshons, W.V., M.E. Lieberman, and J. Gorski, 1984. Nuclear localization of unoccupied 
oestrogen receptors. Nature 307: 747-9. 
Wild, P., D. Bitterli, and M. Becker, 1982. Quantitative changes of membranes in rat 
parathyroid cells related to variations of serum calcium. Laboratory Investigation 47: 
370-4. 
Wild, P., E.M. Schraner, and E. Eggenberger, 1984. Quantitative aspects of membrane shifts 
in rat parathyroid cells initiated by decrease in serum calcium. Biology of the Cell 50: 
263-72. 
Wild, P., S. Gloor, and E. Vetsch, 1985. Quantitative aspects of membrane behavior in rat 
parathyroid cells after depression or elevation of serum calcium. Laboratory 
Investigation 52: 490-6. 
 31
Wild, P., E.M. Schraner, and P. Santini-Willmes, 1989. Effects of estradiol on parathyroid 
cell activity. Experientia 45: 1121-3. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 32
7 Acknowledgements 
 
An dieser Stelle möchte ich alle danken, deren freundliche Unterstützung und tatkräftige 
Mithilfe zu dieser Arbeit beigetragen haben. Ohne diese Personen hätte ich die vorliegende 
Arbeit neben meinem beruflichen Engagement nicht zu Ende führen können. Mein besonderer 
Dank gilt:  
 
Prof. Dr. P. Wild für das Überlassen des Themas, sowie seine unermüdliche und immer 
geduldige Art, mich mit Rat und Tat zu unterstützen. Auch war mir seine immerwährend 
positive Einstellung eine grosse Hilfe während des Verfassens des schriftlichen Teiles dieser 
Arbeit, 
 
Prof. Dr. T. Thun für die Übernahme des Korreferats,  
 
Frau E. M. Schraner für die technische Unterstützung, 
 
lic. Oec. V. Couson für die wertvolle und geduldige Unterstützung bei der Statistik, 
 
Dr. med. vet. FVH G. Stuker für das Durchlesen des Manuskripts, 
 
meinen Mitdoktorandinnen Hélene Leuzinger und Sassa Briner für die unterhaltsamen 
Gespräche während und neben der Arbeit, 
 
meinen Eltern für die liebevolle und finanzielle Unterstützung in den letzten Jahren. 
 
 
  
 
 
 
 
 
 
 33
8 Curriculum Vitae 
 
 
 
Personalien Name:   Sigrist 
 Vorname:  Yvonne 
 Geburtsdatum: 12. Januar 1971 
 Heimatort:  Greifensee 
 Nationalität:  Schweiz 
 Geburtsort:   Uster 
 
 
Ausbildung 1978 - 1984  Primarschule Greifensee, ZH 
1984 - 1987  Sekundarschule Nänikon - Greifensee, ZH 
1990 - 1993  Berufsschule Juventus, Arztgehilfinnenschule,  
  Zürich 
1993 - 1995   Medizinische Laborantin Veterinaria AG, Zürich 
1995 - 1998   Medizinische Laborantin Analytika AG, Zürich 
 
1998 - 2001   Kantonale Maturitätsschule für Erwachsene  
  (KME), Zürich 
 
2001   Eidg. Matura 
 
2001 - 2007 Studium der Veterinärmedizin an der  
 Vetsuisse Fakultät Universität, Zürich 
 
2005 Doktorandin am Veterinär - Anatomischen 
Institut Vetsuisse Fakultät Universität, Zürich 
 
2007 Staatsexamen als Tierärztin, Vetsuisse Fakultät 
Universität, Zürich 
 
2008   Anstellung als Tierärztin, Diavet Labor AG, Bäch  
 
